Table 3.
Age | Type of adrenal mass | Early morning cortisol level, nmol/L (Ref: 100–540 nmol/L) |
Urine metanephrine/creatinine ratio (Ref: <0.10 mmol/mol) | Plasma metanephreines, pmol/L (Ref: < 500pmol/L) | Plasma normetanephrine, pmol/L (Ref: <900 pmol/L) | Aldosterone/renin ratio (Ref: <70) | 17-hydroxyprogesterone, nmol/L (Ref: <70) | Adrenocorticotropic hormone, ng/L (Ref: 7.2–63.3 ng/L) | Estradiol, pmol/L | Follicle-stimulating hormone, IU/L | Luteinising hormone, IU/L | Indication for testing |
---|---|---|---|---|---|---|---|---|---|---|---|---|
75 | Bilateral adrenal adenomas | 67 | - | 362 | 1148 | 42 | 0.4 | 22.1 | < 18 | 2.4 | 0.5 | Fatigue in the context of adrenal tumour |
46* | Bilateral adrenal adenomas | 153 | 0.14 | 148 | 674 | 96 | - | - | - | - | - | Secondary hypertension screen |
36 | Left adrenal adenomas | 78 | - | - | - | 45 | - | - | 142 | 13 | 4 | Fatigue in the context of adrenal tumour |
44* | Bilateral adrenal adenomas | - | - | - | - | 98 | - | - | - | - | - | Secondary hypertension screen |
*: both patients were diagnosed with Conn’s syndrome